<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To investigate the effects of recombinant human endostatin Endostar on <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> and <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> and lymphangiogenesis of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells in a mouse <z:e sem="disease" ids="C1520166" disease_type="Experimental Model of Disease" abbrv="">xenograft model</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0003003'>Colon cancer</z:hpo> cells SW620 were injected subcutaneously into the left hind flank of <z:mp ids='MP_0003815'>nude</z:mp> mice to establish mouse <z:e sem="disease" ids="C1520166" disease_type="Experimental Model of Disease" abbrv="">xenograft models</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The mice were treated with <z:mpath ids='MPATH_458'>normal</z:mpath> saline or Endostar subcutaneously every other day </plain></SENT>
<SENT sid="3" pm="."><plain>The growth and lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells, <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> and lymphangiogenesis in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissue were detected </plain></SENT>
<SENT sid="4" pm="."><plain><z:mpath ids='MPATH_3'>Apoptosis</z:mpath> and cell cycle distribution were studied by flow cytometry </plain></SENT>
<SENT sid="5" pm="."><plain>The expression of VEGF-A, -C, or -D in SW620 cells was determined by immunoblotting assays </plain></SENT>
<SENT sid="6" pm="."><plain>Endostar inhibited <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> and the rate of lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (P &lt; 0.01) </plain></SENT>
<SENT sid="7" pm="."><plain>The density of blood vessels in or around the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> area was 12.27 ± 1.21 and 22.25 ± 2.69 per field in Endostar-treated mice and controls (P &lt; 0.05), respectively </plain></SENT>
<SENT sid="8" pm="."><plain>Endostar also decreased the density of lymphatic vessels in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissues (7.84 ± 0.81 vs. 13.83 ± 1.08, P &lt; 0.05) </plain></SENT>
<SENT sid="9" pm="."><plain>Endostar suppresses <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> and lymphangiogenesis in the lymph nodes with <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e>, simultaneously </plain></SENT>
<SENT sid="10" pm="."><plain>The expression of VEGF-A, -C and -D in SW620 cells treated with Endostar was substantially lower than that of controls </plain></SENT>
<SENT sid="11" pm="."><plain>Endostar inhibited growth and lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> of <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells by inhibiting <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> and lymphangiogenesis in a mouse <z:e sem="disease" ids="C1520166" disease_type="Experimental Model of Disease" abbrv="">xenograft model</z:e> of <z:hpo ids='HP_0003003'>colon cancer</z:hpo> </plain></SENT>
</text></document>